NOVETIDE LTD has a total of 31 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Israel. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are GENMAB BV, PANDION THERAPEUTICS INC and LYVGEN BIOPHARMA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Israel | 5 | |
#4 | United States | 4 | |
#5 | Canada | 2 | |
#6 | Greece | 1 | |
#7 | Mexico | 1 | |
#8 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Eidelman Chaim | 21 |
#2 | Tovi Avi | 17 |
#3 | Alon Hagi | 16 |
#4 | Shushan Shimon | 15 |
#5 | Ivchenko Alexander | 13 |
#6 | Butilca Gabriel-Marcus | 12 |
#7 | Elster Shai | 11 |
#8 | Bar-Oz Leah | 8 |
#9 | Gadi Tehila | 7 |
#10 | Zaoui Gil | 6 |
Publication | Filing date | Title |
---|---|---|
WO2020190757A1 | Improved processes for the preparation of semaglutide | |
WO2017004510A2 | Solid state forms of linaclotide | |
GR20140100479A | Synthesis of liraglutide | |
WO2011066386A1 | Process for production of degarelix | |
US2011160431A1 | Production of peptides containing poly-gly sequences using fmoc chemistry | |
EP2057183A2 | High purity peptides | |
WO2007033383A2 | Process for production of bivalirudin | |
EP2119725A1 | Methods for the production of leuprolide | |
CA2582083A1 | A counterion exchange process for peptides | |
EP1511761A1 | Process for production of cyclic peptides | |
IL134270D0 | Diversified core structure for presentation of biologically active compounds |